Patent US3865548A successfully refreshed from Google Patents.
Patent US4517172A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4517172A Expired / Lapsed US ⏱️ 0.0 years remaining

Plaque disclosing agent

Assignee: Vipont Pharmaceutical Inc
•
Filing: 1983-12-29
•
Granted: 1985-05-14
•
Expires: 2003-12-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Salts of sanguinarine, either pure salts or a mixture of said salts precipitated from extracts of plants selected from the group consisting of Sanguinaria canadensis, Macleya cordata, Corydalis sevctvozii, C. ledebouni, Chelidonium majus, and mixtures thereon, are effective agents for disclosing plaque in the oral cavity under long wavelength ultraviolet light.

Inventors

  • 👤 George L. Southard

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 18:21
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/49; A61Q; A61Q11/00; A61K2800/00; A61K2800/40; A61K2800/42; A61K2800/43

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 76 words
A method for visualizing plaque formation in the oral cavity and rendering such plaque formation visible to the naked eye under long wavelength ultraviolet light by applying to the oral cavity a sanguinarine salt selected from the group consisting of sanguinarine chloride, sanguinarine nitrate, sanguinarine sulfate, and a mixture of said salts precipitated from extracts of plants selected from the group consisting of Sanguinaria canadensis, Macleaya cordata, Corydalis sevctvozii, C. ledebouni, Chelidonium majus, and mixtures thereof.
Claim 2
Independent Claim 76 words
A method for visualizing plaque formation in the oral cavity and rendering such plaque formation visible to the naked eye under long wavelength ultraviolet light by applying to the oral cavity a sanguinarine salt selected from the group consisting of sanguinarine chloride, sanguinarine nitrate, sanguinarine sulfate, and a mixture of said salts precipitated from extracts of plants selected from the group consisting of Sanguinaria canadensis, Macleaya cordata, Corydalis sevctvozii, C. ledebouni, Chelidonium majus, and mixtures thereof.
Claim 3
Dependent Claim 12 words
The method of claim 1 wherein the sanguinarine salt is sanguinarine chloride.
Claim 4
Dependent Claim 15 words
The method of claim 1 wherein the sanguinarine salt is contained in an oral rinse.
Claim 5
Dependent Claim 12 words
The method of claim 3 wherein the sanguinarine salt is sanguinarine chloride.
Claim 6
Dependent Claim 19 words
The method of claim 3 wherein the sanguinarine salt is a mixture of benzophenanthridine salts extracted from Sanguinaria canadensis.
Claim 7
Dependent Claim 17 words
The method of claim 1 wherein the sanguinarine salt is applied in the form of a toothpaste.
Claim 8
Dependent Claim 12 words
The method of claim 6 wherein the sanguinarine salt is sanguinarine chloride.
Claim 9
Dependent Claim 17 words
The method of claim 1 wherein the sanguinarine salt is applied in the form of a toothpowder.

References Cited (Backward Citations)

US209331A Cited
US2344830A Cited
US3309274A Cited
US4145412A Cited
DE2907406A1 Cited
GB2042336A Cited
US4335110A Cited
BE888843A Cited
US4406881A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-05-13 1988-11-12 1989-05-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-05-13 1992-11-12 1993-05-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-05-13 1996-11-12 1997-05-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag